| Prod.# | Product | Size |
| Effective 01-May-06 | | |
| BV-1001-200 | Annexin V-FITC | 200 Assays |
| BV-1001-1000 | Annexin V-FITC | 1000 Assays |
| BV-1002-200 | Annexin V-Cy3 | 200 Assays |
| BV-1002-1000 | Annexin V-Cy3 | 1000 Assays |
| BV-1003-100 | Annexin V-Biotin | 100 ug |
| BV-1004-200 | Annexin V-EGFP | 200 Assays |
| BV-1004-1000 | Annexin V-EGFP | 1000 Assays |
| BV-1005-100 | Annexin V | 100 ug |
| BV-1006-100 | Annexin V Binding Buffer (10x) | 100 ml |
| BV-1007-1000 | Caspase-3 Substrate, DEVD-AFC | 1000 Assays |
| BV-1007-200 | Caspase-3 Substrate, DEVD-AFC | 200 Assays |
| BV-1008-1000 | Caspase-3 Substrate, DEVD-pNA | 1000 Assays |
| BV-1008-200 | Caspase-3 Substrate, DEVD-pNA | 200 Assays |
| BV-1009-100 | Caspase-3 Inhibitor, Z-DEVD-FMK, 2 mM | 100 ul |
| BV-1009-20C | Caspase-3 Inhibitor, Z-DEVD-FMK, 10 mM | 20 ul |
| BV-1010-100 | Caspase-Family Inhibitor, Z-VAD-FMK, 2 mM | 100 ul |
| BV-1010-20C | Caspase-Family Inhibitor, Z-VAD-FMK, 10 mM | 20 ul |
| BV-1011-100 | Caspase-6 Inhibitor, Z-VEID-FMK, 2 mM | 100 ul |
| BV-1011-20C | Caspase-6 Inhibitor, Z-VEID-FMK, 10 mM | 20 ul |
| BV-1012-100 | Caspase-1 Inhibitor, YVAD-FMK, 2 mM | 100 ul |
| BV-1012-20C | Caspase-1 Inhibitor, YVAD-FMK, 10 mM | 20 ul |
| BV-1013-1000 | Annexin V-Cy5 | 1000 Assays |
| BV-1013-200 | Annexin V-Cy5 | 200 Assays |
| BV-1014-1000 | Annexin V-PE | 1000 Assays |
| BV-1014-200 | Annexin V-PE | 200 Assays |
| BV-1015-1000 | Annexin V-PE-Cy5 | 1000 Assays |
| BV-1015-200 | Annexin V-PE-Cy5 | 200 Assays |
| BV-1035-100 | Annexin V Binding Buffer (1x) | 100 ml |
| BV-1036-50 | Actinomycin D, 10 mM | 50 ul |
| BV-1036-5MG | Actinomycin D | 5 mg |
| BV-1039-1 | Camptothecin, 2 mM | 1 ml |
| BV-1039-50MG | Camptothecin | 50 mg |
| BV-1041-1 | Cycloheximide, 100 mM | 1 ml |
| BV-1041-1G | Cycloheximide | 1 g |
| BV-1042-1 | Dexamethasone, 10 mM | 1 ml |
| BV-1042-1G | Dexamethasone | 1 g |
| BV-1043-100 | Etoposide, 100 mM | 100 ul |
| BV-1043-25MG | Etoposide | 25 mg |
| BV-1048-010 | Staurosporine | 100 ug |
| BV-1050-10 | TNF-alpha (human) (rec.) | 10 ug |
| BV-1050-50 | TNF-alpha (human) (rec.) | 50 ug |
| BV-1051-10 | TNF-alpha (mouse) (rec.) | 10 ug |
| BV-1051-20 | TNF-alpha (mouse) (rec.) | 20 ug |
| BV-1052-10 | TNF-alpha (rat) (rec.) | 10 ug |
| BV-1052-20 | TNF-alpha (rat) (rec.) | 20 ug |
| BV-1056-1 | Propidium Iodide (1 mg/ml) | 1 ml |
| BV-1062-1000 | Caspase-8 Fluorometric Substrate, IETD-AFC | 1000 Assays |
| BV-1062-200 | Caspase-8 Fluorometric Substrate, IETD-AFC | 200 Assays |
| BV-1063-1000 | Caspase-8 Colorimetric Substrate, IETD-pNA | 1000 Assays |
| BV-1063-200 | Caspase-8 Colorimetric Substrate, IETD-pNA | 200 Assays |
| BV-1064-100 | Caspase-8 Apoptosis Inhibitor, Z-IETD-FMK, 2 mM | 100 ul |
| BV-1064-20C | Caspase-8 Apoptosis Inhibitor, Z-IETD-FMK, 10 mM | 20 ul |
| BV-1065-200 | MitoCapture Incubation Buffer | 200 ml |
| BV-1066-100 | Dilution Buffer (use with colorimetric caspase assay) | 100 ml |
| BV-1066-500 | Dilution Buffer (use with colorimetric caspase assay) | 500 ml |
| BV-1067-100 | Cell Lysis Buffer (lyse both tissues and cells) | 100 ml |
| BV-1067-400 | Cell Lysis Buffer (lyse both tissues and cells) | 400 ml |
| BV-1068-20 | Reaction Buffer (for 250 caspase assays) (2x) | 20 ml |
| BV-1068-80 | Reaction Buffer (for 1000 caspase assays) (2x) | 80 ml |
| BV-1069-1000 | Caspase-6 Fluorometric Substrate, VEID-AFC | 1000 Assays |
| BV-1069-200 | Caspase-6 Fluorometric Substrate, VEID-AFC | 200 Assays |
| BV-1070-1000 | Caspase-6 Colorimetric Substrate, VEID-pNA | 1000 Assays |
| BV-1070-200 | Caspase-6 Colorimetric Substrate, VEID-pNA | 200 Assays |
| BV-1071-1000 | Caspase-2 Fluorometric Substrate, VDVAD-AFC | 1000 Assays |
| BV-1071-200 | Caspase-2 Fluorometric Substrate, VDVAD-AFC | 200 Assays |
| BV-1072-1000 | Caspase-2 Colorimetric Substrate, VDVAD-pNA | 1000 Assays |
| BV-1072-200 | Caspase-2 Colorimetric Substrate, VDVAD-pNA | 200 Assays |
| BV-1073-100 | Caspase-2 Apoptosis Inhibitor, Z-VDVAD-FMK, 2 mM | 100 ul |
| BV-1073-20C | Caspase-2 Apoptosis Inhibitor, Z-VDVAD-FMK, 10 mM | 20 ul |
| BV-1074-100 | Caspase-9 Apoptosis Inhibitor, Z-LEHD-FMK, 2 mM | 100 ul |
| BV-1074-20C | Caspase-9 Apoptosis Inhibitor, Z-LEHD-FMK, 10 mM | 20 ul |
| BV-1075-1000 | Caspase-9 Fluorometric Substrate, LEHD-AFC | 1000 Assays |
| BV-1075-200 | Caspase-9 Fluorometric Substrate, LEHD-AFC | 200 Assays |
| BV-1076-1000 | Caspase-9 Colorimetric Substrate, LEHD-pNA | 1000 Assays |
| BV-1076-200 | Caspase-9 Colorimetric Substrate, LEHD-pNA | 200 Assays |
| BV-1077-100 | AFC [7-Amino-4-trifluoromethylcoumarin] | 100 mg |
| BV-1078-100 | pNA [p-Nitroaniline] | 100 mg |
| BV-1079-100 | Caspase-12 Inhibitor, Z-ATAD-FMK | 100 ul |
| BV-1079-20C | Caspase-12 Inhibitor, Z-ATAD-FMK | 20 ul |
| BV-1081-100 | Caspase-1 (active) (human) (rec.) | 100 Units |
| BV-1081-25 | Caspase-1 (active) (human) (rec.) | 25 Units |
| BV-1082-100 | Caspase-2 (active) (human) (rec.) | 100 Units |
| BV-1082-25 | Caspase-2 (active) (human) (rec.) | 25 Units |
| BV-1083-100 | Caspase-3 (active) (human) (rec.) | 100 Units |
| BV-1083-25 | Caspase-3 (active) (human) (rec.) | 25 Units |
| BV-1083-5 | Caspase-3 (active) (human) (rec.) | 5 ug |
| BV-1083P-5 | Procaspase-3 (human) (rec.) | 5 ug |
| BV-1084-100 | Caspase-4 (active) (human) (rec.) | 100 Units |
| BV-1084-25 | Caspase-4 (active) (human) (rec.) | 25 Units |
| BV-1085-100 | Caspase-5 (active) (human) (rec.) | 100 Units |
| BV-1085-25 | Caspase-5 (active) (human) (rec.) | 25 Units |
| BV-1086-100 | Caspase-6 (active) (human) (rec.) | 100 Units |
| BV-1086-25 | Caspase-6 (active) (human) (rec.) | 25 Units |
| BV-1087-100 | Caspase-7 (active) (human) (rec.) | 100 Units |
| BV-1087-25 | Caspase-7 (active) (human) (rec.) | 25 Units |
| BV-1087P-5 | Procaspase-7 (human) (rec.) | 5 ug |
| BV-1088-100 | Caspase-8 (active) (human) (rec.) | 100 Units |
| BV-1088-25 | Caspase-8 (active) (human) (rec.) | 25 Units |
| BV-1089-100 | Caspase-9 (active) (human) (rec.) | 100 Units |
| BV-1089-25 | Caspase-9 (active) (human) (rec.) | 25 Units |
| BV-1089P-50 | Procaspase-9 (human) (rec.) | 50 ug |
| BV-1090A-100 | Caspase-10a/Mch4 (active) (human) (rec.) | 100 Units |
| BV-1090A-25 | Caspase-10a/Mch4 (active) (human) (rec.) | 25 Units |
| BV-1090B-100 | Caspase-10b/Flice2 (active) (human) (rec.) | 100 Units |
| BV-1090B-25 | Caspase-10b/Flice2 (active) (human) (rec.) | 25 Units |
| BV-1100-100 | Caspase-5 Inhibitor, Z-WEHD-FMK, 2 mM | 100 ul |
| BV-1100-20C | Caspase-5 Inhibitor, Z-WEHD-FMK, 10 mM | 20 ul |
| BV-1101-1000 | Caspase-5 Substrate, WEHD-AFC | 1000 Assays |
| BV-1101-200 | Caspase-5 Substrate, WEHD-AFC | 200 Assays |
| BV-1102-1000 | Caspase-5 Substrate, WEHD-pNA | 1000 Assays |
| BV-1102-200 | Caspase-5 Substrate, WEHD-pNA | 200 Assays |
| BV-1103-1000 | Caspase-1 Substrate, YVAD-AFC | 1000 Assays |
| BV-1103-200 | Caspase-1 Substrate, YVAD-AFC | 200 Assays |
| BV-1104-1000 | Caspase-1 Substrate, YVAD-pNA | 1000 Assays |
| BV-1104-200 | Caspase-1 Substrate, YVAD-pNA | 200 Assays |
| BV-1106-1000 | Jurkat Cytosolic Extract (Uninduced) | 1 mg |
| BV-1106-400 | Jurkat Cytosolic Extract (Uninduced) | 0.4 mg |
| BV-1107-1000 | Jurkat Cytosolic Extract (Induced) | 1 mg |
| BV-1107-400 | Jurkat Cytosolic Extract (Induced) | 0.4 mg |
| BV-1108-100 | Caspase-4 Apoptosis Inhibitor, Z-LEVD-FMK, 2 mM | 100 ul |
| BV-1108-20C | Caspase-4 Apoptosis Inhibitor, Z-LEVD-FMK, 10 mM | 20 ul |
| BV-1109-1000 | Caspase-4 Fluorometric Substrate, LEVD-AFC | 1000 Assays |
| BV-1109-200 | Caspase-4 Fluorometric Substrate, LEVD-AFC | 200 Assays |
| BV-1110-1000 | Caspase-4 Colorimetric Substrate, LEVD-pNA | 1000 Assays |
| BV-1110-200 | Caspase-4 Colorimetric Substrate, LEVD-pNA | 200 Assays |
| BV-1112-100 | Caspase-10 Apoptosis Inhibitor, Z-AEVD-FMK, 2 mM | 100 ul |
| BV-1112-20C | Caspase-10 Apoptosis Inhibitor, Z-AEVD-FMK, 10 mM | 20 ul |
| BV-1113-1000 | Caspase-10 Fluorometric Substrate, AEVD-AFC | 1000 Assays |
| BV-1113-200 | Caspase-10 Fluorometric Substrate, AEVD-AFC | 200 Assays |
| BV-1114-1000 | Caspase-10 Colorimetric Substrate, AEVD-pNA | 1000 Assays |
| BV-1114-200 | Caspase-10 Colorimetric Substrate, AEVD-pNA | 200 Assays |
| BV-1115-100 | Caspase-13 Apoptosis Inhibitor, Z-LEED-FMK, 2 mM | 100 ul |
| BV-1115-20C | Caspase-13 Apoptosis Inhibitor, Z-LEED-FMK, 10 mM | 20 ul |
| BV-1116-1000 | Caspase-13 Fluorometric Substrate, LEED-AFC | 1000 Assays |
| BV-1116-200 | Caspase-13 Fluorometric Substrate, LEED-AFC | 200 Assays |
| BV-1117-1000 | Caspase-12 Fluorometric Substrate, ATAD-AFC | 1000 Assays |
| BV-1117-200 | Caspase-12 Fluorometric Substrate, ATAD-AFC | 200 Assays |
| BV-1120-20C | Caspase-Familiy Inhibitor, Boc-D-FMK | 20 ul |
| BV-1121-20C | Caspase-8 Inhibitor, IETD-FMK (Biotin) | 20 ul |
| BV-1122-100 | FMK Negative Control, Z-FA-FMK, 2 mM | 100 ul |
| BV-1122-20C | FMK Negative Control, Z-FA-FMK, 10 mM | 20 ul |
| BV-1123-20C | VAD-FMK, 10 mM (Biotin) | 20 ug |
| BV-1124-20C | DEVD-FMK, 10 mM (Biotin) | 20 ug |
| BV-1125-20C | Calpain Inhibitor, Z-LLT-FMK, 10 mM | 20 ul |
| BV-1126-20C | Cathepsin B&L Inhibitor, Z-Phe-Phe-FMK, 10 mM | 20 ul |
| BV-1127-20C | EMAP-II Inhibitor, Z-ASTD-FMK, 10 mM | 20 ug |
| BV-1128-20C | Granzyme B Inhibitor, Z-AAD-CH2Cl | 20 ul |
| BV-1130-5 | JC-1 | 5 mg |
| BV-1131-1 | (Asp)2-Rhodamine 110 (D2R) | 1 mg |
| BV-1134-100 | Calpain I (active) (human) | 100 ug |
| BV-1135-100 | Cathepsin L (active) (human) | 100 mg |
| BV-1136-10 | Histone Protein | 10 mg |
| BV-1137-100 | HAT [P/CAF] (active) (rec.) | 100 ug |
| BV-1138-100K | Streptokinase | 100'000 units |
| BV-1181-100 | Caspase-1 (active) (mouse) (rec.) | 100 units |
| BV-1181-25 | Caspase-1 (active) (mouse) (rec.) | 25 units |
| BV-1183-100 | Caspase-3 (active) (mouse) (rec.) | 100 Units |
| BV-1183-25 | Caspase-3 (active) (mouse) (rec.) | 25 Units |
| BV-1183P-5 | Procaspase-3 (mouse) (rec.) | 5 ug |
| BV-1201-1 | DTT (1M) | 1 ml |
| BV-1203-10 | Ethidium Bromide (1 mg/ml) | 10 ml |
| BV-1209-10 | Trypan Blue | 10 ml |
| BV-1211-20 | Mounting Medium | 20 ml |
| BV-1241-1 | L-Glutathione (oxidized form, GSSG) | 1 g |
| BV-1242-1 | L-Glutathione (reduced form, GSSG) | 1 g |
| BV-1243-1 | GST Protein (active) | 1 mg |
| BV-1266-100 | CaspGLOW Wash Buffer | 100 ml |
| BV-1267-1 | Rabbit Serum | 1 ml |
| BV-1268-100 | Rabbit IgG | 100 ug |
| BV-1283-100 | Caspase-3 (active) (rat) (rec.) | 100 Units |
| BV-1283-25 | Caspase-3 (active) (rat) (rec.) | 25 Units |
| BV-1501-10 | A23187 | 10 mg |
| BV-1505-100 | Arachidonic acid | 100 mg |
| BV-1506-1000 | Aurintricarboxylic acid | 1 g |
| BV-1519-1000 | Colchicine | 1 g |
| BV-1522-100 | Cyclosporine A | 100 mg |
| BV-1524-10 | Daunorubicin . HCl | 10 mg |
| BV-1527-5 | Doxorubicin . HCl | 5 mg |
| BV-1531-5 | Forskolin | 5 mg |
| BV-1533-10 | Genistein | 10 mg |
| BV-1533-100 | Genistein | 100 mg |
| BV-1535-10 | Genistin | 10 mg |
| BV-1543-025 | Okadaic acid | 25 ug |
| BV-1544-5 | Phorbol-12-myristate 13-acetate | 5 mg |
| BV-1548-5 | PMSF | 5 g |
| BV-1549-10 | Anisomycin (JNK Activators) | 10 mg |
| BV-1550-1000 | Cisplatin | 1 g |
| BV-1551-1000 | Tamoxifen citrate | 1 g |
| BV-1552-25 | Betulinic acid | 25 mg |
| BV-1553-100 | Carboplatin | 100 mg |
| BV-1554-10 | Pifithrin-alpha | 10 mg |
| BV-1555-1000 | GST Inhibitor-1 (Cibacron Blue F3G-A) | 1 g |
| BV-1556-1000 | GST Inhibitor-2 (Ethacrynic acid) | 1 g |
| BV-1557-1000 | G418 Sulfate (siRNA Vector Approved) | 1 g |
| BV-1558-1 | Thapsigargin | 1 mg |
| BV-1559-5 | Rosiglitazone | 5 mg |
| BV-1560-5 | Brefeldin A | 5 mg |
| BV-1561-50 | Mifepristone | 50 mg |
| BV-1562-025 | Calyculin A | 25 ug |
| BV-1563-1 | FK-506 | 1 mg |
| BV-1564-1 | Geldanamycin | 1 mg |
| BV-1565-5 | Ionomycin (free acid) | 5 mg |
| BV-1566-5 | Ionomycin (Calcium salt) | 5 mg |
| BV-1567-25 | Paclitaxel | 25 mg |
| BV-1568-5 | Rapamycin | 5 mg |
| BV-1569-01 | Thymeleatoxin | 100 ug |
| BV-1570-5 | Tyrphostin AG 490 | 5 mg |
| BV-1571-5 | Tyrphostin AG 1295 | 5 mg |
| BV-1601-1 | Apicidin (HDAC Inhibitors) | 1 mg |
| BV-1604-1 | SAHA | 1 mg |
| BV-1605-1 | Scriptaid | 1 mg |
| BV-1606-1 | Trichostatin A (HDAC Inhibitors) | 1 mg |
| BV-1607-1 | M344 | 1 mg |
| BV-1608-100 | Sodium 4-phenylbutyrate | 100 mg |
| BV-1609-1000 | Sodium butyrate | 1 g |
| BV-1641-1 | HeLa Nuclear Extract | 1 mg |
| BV-1701-1 | Akt Inhibitor | 1 mg |
| BV-1998-1 | Dounce Tissue Grinder | 1 ea |
| BV-1999-1 | Magnetic Separator | 1 ea |
| BV-2001-2500 | Terminal Transferase (TdT) | 2500 units |
| BV-2001-500 | Terminal Transferase (TdT) | 500 units |
| BV-2101-100 | Sodium Chloride Solution (NaCl, 5 M) | 100 ml |
| BV-2102-100 | SDS Solution (10% in H2O) | 100 ml |
| BV-2103-100 | EDTA Solution (0.5 M, pH 8.0) | 100 ml |
| BV-2104-100 | Triton X-100 Solution (10% in H2O) | 100 ml |
| BV-2105-100 | Magnesium Chloride (MgCl2, 1 M) | 100 ml |
| BV-2106-100 | Tris-HCl (1 M, pH 6.8) | 100 ml |
| BV-2107-100 | Tris-HCl (1 M, pH 8.8) | 100 ml |
| BV-2108-10 | SDS-PAGE Loading Buffer (3x) | 10 ml |
| BV-2109-100 | Tween 20 Solution (10% in H2O) | 100 ml |
| BV-2110-10 | Orange G Loading Buffer | 10 ml |
| BV-2111-100 | Np-40 (10% in H2O) | 100 ml |
| BV-2113-500 | Phosphate Buffered Saline (PBS, 1X) | 500 ml |
| BV-2115-100 | Potassium Chloride Solution (KCl, 1 M) | 100 ml |
| BV-2118-100 | Sodium Acetate (NaAc, 3 M, pH5.2) | 100 ml |
| BV-2120-100 | Cytochrome c (95% pure, no TCA) | 100 mg |
| BV-2121-100 | ATP (100mM) | 100 ul |
| BV-2221-10 | Advanced Glycation Endproduct -BSA | 10 mg |
| BV-2401-100 | Jurkat Cell Lysate (untreated) | 100 ug |
| BV-2402-100 | Jurkat Cell Lysate (Camptothecin-treated) | 100 ug |
| BV-2601-100 | Small IntestineTissue Lysate (mouse) | 100 ug |
| BV-2701-100 | Brain Tissue Lysate (rat) | 100 ug |
| BV-2702-100 | Kidney Tissue Lysate (rat) | 100 ug |
| BV-2703-100 | Heart Tissue Lysate (rat) | 100 ug |
| BV-2704-100 | Liver Tissue Lysate (rat) | 100 ug |
| BV-2705-100 | Thymus Tissue Lysate (rat) | 100 ug |
| BV-3001-100 | MAb to PARP | 100 ug |
| BV-3002-100 | PAb to PARP | 100 ug |
| BV-3002BP-50 | Blocking Peptide for PAb to PARP (BV-3002) | 50 ug |
| BV-3003-100 | MAb to Bcl-2 (7T) | 100 ug |
| BV-3004-100 | MAb to Caspase-3 (C33) | 100 ug |
| BV-3005-100 | MAb to Bad | 100 ug |
| BV-3006-100 | MAb to Bcl-x (44T) | 100 ug |
| BV-3007-100 | MAb to Caspase-3 (T46L) | 100 ug |
| BV-3008-100 | MAb to FADD (ms) | 100 ug |
| BV-3010-100 | MAb to Caspase-7 (ms) | 100 ug |
| BV-3011-100 | MAb to Bax | 100 ug |
| BV-3012-100 | MAb to NFkappaBp65 | 100 ug |
| BV-3013-100 | MAb to TRADD | 100 ug |
| BV-3015-100 | PAb to Caspase-3 | 100 ug |
| BV-3015BP-50 | Blocking Peptide for PAb to Caspase-3 (BV-3015) | 50 ug |
| BV-3016-100 | PAb to Caspase-9 | 100 ug |
| BV-3016BP-50 | Blocking Peptide for PAb to Caspase-9 (BV-3016) | 50 ug |
| BV-3017-100 | PAb to Caspase-10 | 100 ug |
| BV-3018-100 | PAb to Apaf-1 | 100 ug |
| BV-3019-100 | PAb to Caspase-1 | 100 ug |
| BV-3019BP-50 | Blocking Peptide for PAb to Caspase-1 ( BV-3019) | 50 ug |
| BV-3020-100 | PAb to Caspase-8 | 100 ug |
| BV-3020BP-50 | Blocking Peptide for PAb to Caspase-8 ( BV-3020) | 50 ug |
| BV-3021-100 | PAb to Caspase-11 | 100 ug |
| BV-3021BP-50 | Blocking Peptide for PAb to Caspase-11 ( BV-3021) | 50 ug |
| BV-3023-100 | PAb to Caspase-6 | 100 ug |
| BV-3024-100 | PAb to Caspase-7 | 100 ug |
| BV-3024BP-50 | Blocking Peptide for PAb to Caspase-7 (BV-3024) | 50 ug |
| BV-3025-100 | PAb to Cytochrome c | 100 ug |
| BV-3025BP-50 | Blocking Peptide for PAb to Cytochrome c ( BV-3025) | 50 ug |
| BV-3026-100 | MAb to Cytochrome c | 100 ug |
| BV-3027-100 | PAb to Caspase-2 | 100 ug |
| BV-3027BP-50 | Blocking Peptide for PAb to Caspase-2 ( BV-3027) | 50 ug |
| BV-3028-100 | PAb to Caspase-4 | 100 ug |
| BV-3029-100 | PAb to Caspase-5 | 100 ug |
| BV-3030-100 | PAb to Bad | 100 ug |
| BV-3031-100 | PAb to Bak | 100 ug |
| BV-3032-100 | PAb to Bax | 100 ug |
| BV-3033-100 | PAb to Bcl-2 | 100 ug |
| BV-3034-100 | PAb to Bcl-w | 100 ug |
| BV-3035-100 | PAb to Mcl-1 | 100 ug |
| BV-3036-100 | MAb to p53 | 100 ug |
| BV-3037-100 | PAb to RAIDD | 100 ug |
| BV-3038-100 | PAb to NFkappaBp65 | 100 ug |
| BV-3039-100 | PAb to FADD | 100 ug |
| BV-3040-100 | PAb to Bag-1 | 100 ug |
| BV-3041-100 | PAb to Bcl-x | 100 ug |
| BV-3042-100 | PAb to Bid Goat | 100 ug |
| BV-3043-100 | PAb to Bok | 100 ug |
| BV-3044-100 | PAb to PBR | 100 ug |
| BV-3044BP-50 | Blocking Peptide for PAb to PBR ( BV-3044) | 50 ug |
| BV-3045-100 | PAb to TRAIL | 100 ug |
| BV-3046-100 | MAb to Lamin B1 (2L-5) | 100 ug |
| BV-3047-100 | PAb to DFF45 (human) | 100 ug |
| BV-3048-100 | PAb to DFF45 | 100 ug |
| BV-3049-100 | PAb to DFF40 | 100 ug |
| BV-3050-100 | MAb to DFF45 (human) | 100 ug |
| BV-3051-100 | MAb to Caspase-8 (C15S) | 100 ug |
| BV-3052-100 | PAb to TNF-alpha (human) | 100 ug |
| BV-3053-100 | PAb to TNF-alpha (murine) | 100 ug |
| BV-3054-100 | PAb to TNF-alpha (rabbit) | 100 ug |
| BV-3055-100 | MAb to TNF-alpha | 100 ug |
| BV-3057-100 | PAb to DR3/Apo3 | 100 ug |
| BV-3058-100 | PAb to c-FLIP | 100 ug |
| BV-3060-100 | PAb to DcR2 | 100 ug |
| BV-3061-100 | PAb to DR4 | 100 ug |
| BV-3062-100 | PAb to DR5 | 100 ug |
| BV-3066-100 | PAb to MADD | 100 ug |
| BV-3067-100 | PAb to SHPS-1/SIRP-1alpha | 100 ug |
| BV-3069-100 | PAb to Zip Kinase | 100 ug |
| BV-3070-100 | PAb to Fas/Apo1 | 100 ug |
| BV-3071-100 | PAb to CD27 | 100 ug |
| BV-3072-100 | PAb to CD40 | 100 ug |
| BV-3073-100 | MAb to Granzyme B (B18.1) | 100 ug |
| BV-3075-100 | PAb to Calcineurin A | 100 ug |
| BV-3076-100 | MAb to Calreticulin | 100 ug |
| BV-3077-100 | PAb to Calreticulin | 100 ug |
| BV-3080-100 | PAb to Cdc42/Rac | 100 ug |
| BV-3084-100 | PAb to Cytochrome p450 | 100 ug |
| BV-3085-100 | PAb to Erk1/2 (MAPK) | 100 ug |
| BV-3092-100 | PAb to Hsp27 | 100 ug |
| BV-3094-100 | MAb to Hsp60 (LK-1) | 100 ug |
| BV-3095-100 | PAb to Hsc70 | 100 ug |
| BV-3096-100 | MAb to Hsp70 (S5) | 100 ug |
| BV-3097-100 | PAb to Hsp70 | 100 ug |
| BV-3098-100 | MAb to Hsp90 (S88) | 100 ug |
| BV-3100-100 | PAb to MAPKAPK-2 | 100 ug |
| BV-3111-100 | PAb to Mek1 | 100 ug |
| BV-3114-100 | PAb to p38 MAP Kinase | 100 ug |
| BV-3115-100 | PAb to PKA | 100 ug |
| BV-3116-100 | PAb to Raf1 | 100 ug |
| BV-3120-100 | PAb to Wee1 | 100 ug |
| BV-3123-100 | PAb to Daxx | 100 ug |
| BV-3124-100 | PAb to Bim/Bod | 100 ug |
| BV-3125-100 | PAb to TNF-R1 | 100 ug |
| BV-3126-100 | MAb to 14-3-3 | 100 ug |
| BV-3127-100 | PAb to ARC | 100 ug |
| BV-3128-100 | PAb to ASK1/MAKKK5 | 100 ug |
| BV-3130-100 | PAb to DNA-PK | 100 ug |
| BV-3131-100 | PAb to IRAK | 100 ug |
| BV-3132-100 | PAb to RICK | 100 ug |
| BV-3133-100 | PAb to Stat1alpha | 100 ug |
| BV-3135-100 | PAb to Caspase-7 | 100 ug |
| BV-3135BP-50 | Blocking Peptide for PAb to Caspase-7 (BV- 3135) | 50 ug |
| BV-3136-100 | PAb to Caspase-9 | 100 ug |
| BV-3136BP-50 | Blocking Peptide for PAb to Caspase-9 ( BV-3136) | 50 ug |
| BV-3138-100 | PAb to Caspase-3 | 100 ug |
| BV-3138BP-50 | Blocking Peptide for PAb to Caspase-3 (BV-3138) | 50 ug |
| BV-3140-100 | PAb to PARP (cleaved) (rabbit) | 100 ug |
| BV-3141-100 | PAb to PARP (cleaved) (mouse) | 100 ug |
| BV-3142-100 | PAb to PARP (cleaved) (rat) | 100 ug |
| BV-3147-100 | PAb to Caspase-7 (active) | 100 ug |
| BV-3149-100 | PAb to Caspase-9 (active) (human) | 100 ug |
| BV-3151-100 | PAb to Caspase-9 (active) (rabbit) | 100 ug |
| BV-3156-100 | PAb to Caspase-6 (active) | 100 ug |
| BV-3158-100 | PAb to Caspase-8 | 100 ug |
| BV-3158BP-50 | Blocking Peptide for PAb to Caspase-8 ( BV-3158) | 50 ug |
| BV-3160-100 | PAb to Survivin (human) | 100 ug |
| BV-3161-100 | PAb to Survivin (mouse) | 100 ug |
| BV-3172-100 | PAb to Bid (rabbit) | 100 ug |
| BV-3172BP-50 | Blocking Peptide for PAb to Bid (rabbit) ( 3172-100) | 50 ug |
| BV-3173-100 | MAb to Granzyme B (O2C5/F5) | 100 ug |
| BV-3175-100 | PAb to BLK | 100 ug |
| BV-3176-100 | PAb to Hrk | 100 ug |
| BV-3178-100 | PAb to CD40L | 100 ug |
| BV-3179-100 | MAb to Caspase-14 | 100 ug |
| BV-3180-100 | PAb to cIAP-1/HIAP-2 | 100 ug |
| BV-3180BP-50 | Blocking Peptide for PAb to cIAP-1 (BV-3180) | 50 ug |
| BV-3181-100 | PAb to cIAP-2/HIAP-1 | 100 ug |
| BV-3181BP-50 | Blocking Peptide for PAb to cIAP-2 (BV-3181) | 50 ug |
| BV-3182-100 | PAb to Caspase-12 | 100 ug |
| BV-3182BP-50 | Blocking Peptide for PAb to Caspase-12 (BV-3182) | 50 ug |
| BV-3183-100 | PAb to XIAP | 100 ug |
| BV-3183BP-50 | Blocking Peptide for PAb to XIAP (BV-3183) | 50 ug |
| BV-3184-100 | PAb to DOK | 100 ug |
| BV-3185-100 | PAb to IKKalpha/IKK-1 | 100 ug |
| BV-3186-100 | PAb to IKKbeta/IKK-2 | 100 ug |
| BV-3187-100 | MAb to Holocytochrome c | 100 ug |
| BV-3188-100 | MAb to Perforin | 100 ug |
| BV-3189-100 | PAb to Calpain I | 100 ul |
| BV-3190-100 | PAb to Cathepsin B | 100 ug |
| BV-3191-100 | PAb to Cathepsin D | 100 ug |
| BV-3192-100 | PAb to Cathepsin L | 100 ug |
| BV-3193-100 | PAb to NIK | 100 ug |
| BV-3194-100 | PAb to TrkA | 100 ug |
| BV-3195-100 | MAb to Bcl-2 | 100 ug |
| BV-3196-100 | PAb to Mek1 | 100 ug |
| BV-3200-100 | PAb to Acinus | 100 ug |
| BV-3201-100 | PAb to Adam10/Kurz | 100 ug |
| BV-3202-100 | PAb to AIF | 100 ug |
| BV-3202BP-50 | Blocking Peptide for PAb to AIF (BV-3202) | 50 ug |
| BV-3203-100 | PAb to BAFF/BLyS | 100 ug |
| BV-3204-100 | PAb to Bcl-10/CIPER/CLAP | 100 ug |
| BV-3205-100 | PAb to Bnip3L | 100 ug |
| BV-3207-100 | PAb to Caspase-13 | 100 ug |
| BV-3209-100 | PAb to CIDE-A | 100 ug |
| BV-3210-100 | PAb to CIDE-A | 100 ug |
| BV-3211-100 | PAb to CIDE-B | 100 ug |
| BV-3212-100 | PAb to DcR1 | 100 ug |
| BV-3213-100 | PAb to DcR3 | 100 ug |
| BV-3214-100 | PAb to Dnase I | 100 ug |
| BV-3215-100 | PAb to DNase II | 100 ug |
| BV-3216-100 | PAb to DR6 | 100 ug |
| BV-3217-100 | PAb to DRAK1 | 100 ug |
| BV-3218-100 | PAb to DRAK2 | 100 ug |
| BV-3219-100 | PAb to FLASH | 100 ug |
| BV-3220-100 | PAb to IRAK-2 | 100 ug |
| BV-3221-100 | PAb to SODD | 100 ug |
| BV-3222-100 | PAb to TACE | 100 ug |
| BV-3228-100 | PAb to NAIP | 100 ug |
| BV-3230-100 | MAb to Cathepsin L | 100 ug |
| BV-3243-100 | PAb to IL-1RAcP | 100 ug |
| BV-3244-100 | PAb to MYD88 | 100 ug |
| BV-3247-100 | PAb to Akt/PKB | 100 ug |
| BV-3248-100 | PAb to PAK1 | 100 ug |
| BV-3249-100 | PAb to Galphai2 | 100 ug |
| BV-3250-100 | PAb to Galpha16 | 100 ug |
| BV-3251-100 | PAb to TLR4 | 100 ug |
| BV-3252-100 | PAb to IkappaBalpha | 100 ug |
| BV-3256-100 | PAb to Caspase-6 | 100 ug |
| BV-3256BP-50 | Blocking Peptide for PAb to Caspase-6 (BV-3256) | 50 ug |
| BV-3257-100 | PAb to Akt (activated)(pSer473) | 100 ug |
| BV-3258-100 | MAb to Caspase-8 (active) | 100 ug |
| BV-3259-100 | PAb to Caspase-8 (active) | 100 ug |
| BV-3259BP-50 | Blocking Peptide for PAb to Caspase-8 (active) (BV-3259) | 50 ug |
| BV-3261-100 | PAb to DAP1 | 100 ug |
| BV-3263-100 | PAb to DAP3 | 100 ug |
| BV-3265-100 | PAb to DAP5 | 100 ug |
| BV-3266-100 | PAb to alpha-Fodrin | 100 ug |
| BV-3267-100 | PAb to Lamin A | 100 ug |
| BV-3269-100 | PAb to Bad (activated)(pSer112) | 100 ug |
| BV-3270-100 | PAb to AFX (activated)(pSer193) | 100 ug |
| BV-3272-100 | PAb to Bid | 100 ug |
| BV-3278-100 | PAb to MSK1 (activated)(pThr581) | 100 ug |
| BV-3279-100 | PAb to RIP | 100 ug |
| BV-3280-100 | PAb to RGS3 | 100 ug |
| BV-3282-100 | PAb to Caspase-12 | 100 ug |
| BV-3282BP-50 | Blocking Peptide for PAb to Caspase-12 (BV-3282) | 50 ug |
| BV-3285-100 | PAb to MKK3 | 100 ug |
| BV-3287-100 | PAb to Perforin | 100 ug |
| BV-3291-100 | PAb to ASC | 100 ug |
| BV-3292-100 | PAb to APRIL | 100 ug |
| BV-3293-100 | PAb to RIP3 | 100 ug |
| BV-3294-100 | PAb to PID | 100 ug |
| BV-3295-100 | PAb to p53R2 | 100 ug |
| BV-3296-100 | PAb to NAK/TBK1 | 100 ug |
| BV-3297-100 | PAb to MTBP | 100 ug |
| BV-3298-100 | PAb to Smac/DIABLO | 100 ug |
| BV-3300-100 | PAb to IRAK-M | 100 ug |
| BV-3301-100 | PAb to IKKgamma | 100 ug |
| BV-3302-100 | PAb to IKKepsilon | 100 ug |
| BV-3303-100 | PAb to DAP Kinase 2 | 100 ug |
| BV-3304-100 | PAb to F1Aalpha | 100 ug |
| BV-3305-100 | PAb to Chk2 | 100 ug |
| BV-3311-100 | PAb to RasGAP | 100 ug |
| BV-3312-100 | PAb to Bcl-xL | 100 ug |
| BV-3313-100 | PAb to DEDAF | 100 ug |
| BV-3314-100 | PAb to CIKS/Act1 | 100 ug |
| BV-3315-100 | MAb to IkappaBalpha | 100 ug |
| BV-3322-100 | MAb to Caspase-2 | 100 ug |
| BV-3328-100 | MAb to Caspase-4 | 100 ug |
| BV-3329-100 | PAb to Caspase-5 | 100 ug |
| BV-3329BP-50 | Blocking Peptide for PAb to Caspase-5 | 50 ug |
| BV-3330-100 | MAb to FasL | 100 ug |
| BV-3331-100 | MAb to Bax | 100 ug |
| BV-3332-100 | PAb to ARTS | 100 ug |
| BV-3334-100 | PAb to Bmf | 100 ug |
| BV-3335-100 | PAb to CARD9 | 100 ug |
| BV-3336-100 | PAb to EndoG | 100 ug |
| BV-3337-100 | PAb to ILP-2 | 100 ug |
| BV-3338-100 | PAb to Livin | 100 ug |
| BV-3339-100 | PAb to PUMA | 100 ug |
| BV-3340-100 | PAb to p53DINP1 | 100 ug |
| BV-3341-100 | PAb to PERP | 100 ug |
| BV-3342-100 | PAb to Oct-1 | 100 ug |
| BV-3343-100 | MAb to FADD | 100 ug |
| BV-3344-100 | PAb to Rb | 100 ug |
| BV-3345-100 | PAb to FasL | 100 ug |
| BV-3346-100 | PAb to FAF1 | 100 ug |
| BV-3347-100 | PAb to Bl-1 | 100 ug |
| BV-3347R-100 | PAb to BI-1 | 100 ug |
| BV-3348-100 | PAb to TANK | 100 ug |
| BV-3349-100 | PAb to ILP-2 | 100 ug |
| BV-3350-100 | PAb to PCNA | 100 ug |
| BV-3350R-100 | PAb to PCNA | 100 ug |
| BV-3351-100 | PAb to Mek2 | 100 ug |
| BV-3352-100 | PAb to Cytochrome c (rat) | 100 ug |
| BV-3353-100 | PAb to Cytochrome c (mouse,bovine) | 100 ug |
| BV-3354-100 | PAb to NF-kappaB p50 | 100 ug |
| BV-3355-100 | PAb to ALK | 100 ug |
| BV-3356-100 | PAb to beta-Amyloid | 100 ug |
| BV-3357-100 | PAb to Annexin V | 100 ug |
